The MUHC is proud and pleased to announce that the Programme québécois de cancérologie (PQC) of...
Animal Resources Division (ARD)The Animal Resources Division (ARD) at the Research Institute of the McGill University Health Centre...
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Thanks to RI-MUHC researchers, trainees and staff for their continued commitment to excellence
BRaIN Program Seminar Series Winter 2022
IDIGH Program Seminar Series Winter 2022
Nature Communications study has implications for treatment of patients and genetic counselling
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
Three key factors might offer 90% accuracy in predicting wide range of psychiatric disorders
MeDiC Program Seminar Series Winter 2022
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
Pan-Canadian team receives financing to develop a national pediatric diabetes registry
Wednesdays, 4 to 5 p.m.
CORE Seminar Series Winter 2022
Recruitment of first U.S.-based patients in dapsone trial has started